This is supported by a recent study reporting that metformin treatment, which increases adiponectin serum levels (70), had no positive effect in patients with IPF (71), possibly due to reduced adiponectin receptor levels (CDH13). Here, ADIPOQ is linked to idiopathic pulmonary fibrosis.